CAM
BPMC icon

ClariVest Asset Management’s Blueprint Medicines BPMC Stock Holding History

ClariVest Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.18M Hold
20,239
– – 0.22% 125
2024
Q2 		$2.18M Buy
20,239
+18
+0.1% +$1.8K 0.22% 125
2024
Q1 		$1.92M Sell
20,221
-105
-0.5% -$9.01K 0.2% 147
2023
Q4 		$1.87M Sell
20,326
-1,411
-6% -$91.4K 0.1% 137
2023
Q3 		$1.09M Buy
21,737
+20
+0.1% +$1.07K 0.06% 220
2023
Q2 		$1.37M Sell
21,717
-3,303
-13% -$180K 0.07% 183
2023
Q1 		$1.13M Buy
25,020
+14
+0.1% +$631 0.05% 271
2022
Q4 		$1.1M Sell
25,006
-79
-0.3% -$3.79K 0.05% 262
2022
Q3 		$1.65M Sell
25,085
-4,861
-16% -$312K 0.08% 187
2022
Q2 		$1.51M Sell
29,946
-5,200
-15% -$305K 0.07% 224
2022
Q1 		$2.25M Sell
35,146
-3,883
-10% -$279K 0.09% 202
2021
Q4 		$4.18M Sell
39,029
-14,925
-28% -$1.56M 0.13% 154
2021
Q3 		$5.55M Buy
53,954
+521
+1% +$48.5K 0.18% 122
2021
Q2 		$4.7M Buy
+53,433
New +$4.9M 0.16% 137
2016
Q1 		– Sell
-10,815
Closed -$285K – 629
2015
Q4 		$285K Buy
10,815
+4,915
+83% +$111K 0.01% 410
2015
Q3 		$126K Buy
5,900
+100
+2% +$2.77K ﹤0.01% 462
2015
Q2 		$153K Buy
+5,800
New +$166K ﹤0.01% 427

Other funds holding BPMC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClariVest Asset Management's BPMC Position: Q3 2024 in Review

ClariVest Asset Management held its Blueprint Medicines (BPMC) position steady in Q3 2024 at 20,239 shares worth $2.18M. The position accounts for 0.22% of the portfolio, ranked #125.

ClariVest Asset Management first reported a position in BPMC in Q2 2015 and has held it in 17 quarters since. The position peaked at $5.55M in Q3 2021. 319 funds tracked by Wall St. Rank hold BPMC as of Q3 2024.

  • ClariVest Asset Management held 20,239 shares of Blueprint Medicines worth $2.18M as of Q3 2024.
  • ClariVest Asset Management left its Blueprint Medicines share count unchanged in Q3 2024.
  • Blueprint Medicines made up 0.22% of ClariVest Asset Management's portfolio in Q3 2024, its #125 holding.
  • ClariVest Asset Management first reported a position in Blueprint Medicines in Q2 2015 and has held it in 17 quarters since.
  • ClariVest Asset Management's Blueprint Medicines position peaked at $5.55M in Q3 2021.
  • 319 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.